A PCR-based microwell-plate hybrid capture assay for high-risk human papillomavirus

详细信息    查看全文

• 作者：Yumei Wang (1)
  Yan Liu (1)
  Yaping Ding (2)
  Nan Sun (1)
  Yafang Gong (3)
  Shangxian Gao (1)
  
• 刊名：Archives of Virology
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：159
• 期：12
• 页码：3365-3370
• 全文大小：323 KB
• 参考文献：1. Kim J, Kim BK, Lee CH, Seo SS, Park SY, Roh JW (2012) Human papillomavirus genotypes and cofactors causing cervical intraepithelial neoplasia and cervical cancer in Korean women. Int J Gynecol Cancer 22(9):1570-576
  2. Williams VM, Filippova M, Soto U, Duerksen-Hughes PJ (2011) HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future Virol 6(1):45-7 CrossRef
  3. Lehoux M, D’Abramo CM, Archambault J (2009) Molecular mechanisms of human papillomavirus-induced carcinogenesis. Public Health Genomics 12(5-):268-80 CrossRef
  4. Pim D, Banks L (2010) Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs low-risk human papillomaviruses. Apmis 118(6-):471-93 CrossRef
  5. Rogovskaya SI, Shabalova IP, Mikheeva IV, Minkina GN, Podzolkova NM, Shipulina OY, Sultanov SN, Kosenko IA, Brotons M, Buttmann N, Dartell M, Arbyn M, Syrjanen S, Poljak M (2013) Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western Countries of the former Soviet Union Caucasus Region and Central Asia. Vaccine 31(Suppl 7):H46–H58 CrossRef
  6. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S (2012) Global burden of human papillomavirus and related diseases. Vaccine 30(Suppl 5):F12–F23 CrossRef
  7. Li J, Huang R, Schmidt JE, Qiao YL (2013) Epidemiological features of human papillomavirus (HPV) infection among women living in Mainland China. Asian Pac J Cancer Prev 14(7):4015-023 CrossRef
  8. Shan J (2014) Cervical cancer increases among young Chinese women. http://news.xinhuanet.com/english/china/2014-04/25/c_133289589.htm
  9. Jeong NH, Lee NW, Kim HJ, Kim T, Lee KW (2009) High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia. J Obstet Gynaecol Res 35(4):706-11 CrossRef
  10. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, Rizzolo R, Schincaglia P, Zorzi M, Zappa M, Segnan N, Cuzick J (2010) Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 11(3):249-57 CrossRef
  11. zur Hausen H (2009) Papillomaviruses in the causation of human cancers—a brief historical account. Virology 384:260-65 CrossRef
  12. Persano S, Valentini P, Kim JH, Pompa PP (2013) Colorimetric detection of human papilloma virus by double isothermal amplification. Chem Commun (Camb) 49(90):10605-0607 CrossRef
  13. Nilyanimit P, Wanlapakorn N, Niruthisard S, Pohthipornthawat N, Karalak A, Laowahutanont P, Phanuphak N, Gemma N, Poovorawan Y (2013) Detection of human papillomavirus in male and female urine by electrochemical DNA chip and PCR sequencing. Asian Pac J Cancer Prev 14(9):5519-525 CrossRef
  14. Eder PS, Lou J, Huff J, Macioszek J (2009) The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform. J Clin Virol 45(Suppl 1):S85–S92 CrossRef
  15. Ju Z, Yane G, Ding L, Guowu Y, Yanhai G, Yonglan L (2009) Asymmetric GP5?+/6?+?PCR and hybridization with fluorescence pol
• 作者单位：Yumei Wang (1)
  Yan Liu (1)
  Yaping Ding (2)
  Nan Sun (1)
  Yafang Gong (3)
  Shangxian Gao (1)
  
  1. Department of In Vitro Diagnostic Reagents, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, No. 2 Tiantanxili, Beijing, 100050, China
  2. Shenzhen Kangmei Biotechnology Co., Ltd, Shenzhen, 518057, China
  3. Third Xiangya Hospital of Central South University, Changsha, 410013, China
  
• ISSN：1432-8798

文摘

Human papillomavirus (HPV) is associated with cervical cancer. In this study, we developed a high-throughput microwell-plate hybrid capture (MPHC) method for epidemiological studies of high-risk HPV (HRHPV). The results with 1238 cervical specimens from female outpatients showed a concordance rate of 94.3?% between the MPHC and Hybrid Capture II assay. The MPHC assay showed an average HRHPV rate of 29.3?% for high-risk populations in populous cities of China. The established MPHC assay could sensitively and specifically detect 13 types of HRHPV and is suitable for large-scale screening, especially in areas where real-time PCR or fluorescence equipment is unavailable.